Glucuronate

Glucuronate

SCHEMBL1820844

Nc1ccc(O)cc1.O=C(O)[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA3 P07451 2/20 0.42
CA14 Q9ULX7 2/20 0.42
HIF1A Q16665 2/20 0.42
THRB P10828 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
CA6 P23280 1/20 0.42
CASP1 P29466 1/20 0.42
HSD17B10 Q99714 1/20 0.42
IDUA P35475 1/20 0.39
APP P05067 2/20 0.39
SLCO2B1 O94956 3/20 0.37
ABCC2 Q92887 2/20 0.37
ABCG2 Q9UNQ0 2/20 0.37
ABCB1 P08183 1/20 0.37
UGT1A1 P22309 1/20 0.37
HTR7 P34969 1/20 0.37
METTL3 Q86U44 1/20 0.37
METTL14 Q9HCE5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glucuronate SCHEMBL28919162 0.92 IDUA (0.41) CA3CA14ALDH1A1CA6IDUA
Glucuronate SCHEMBL28065767 0.92 IDUA (0.41) CA3CA14ALDH1A1CA6IDUA
Glucuronate SCHEMBL28065814 0.92 IDUA (0.41) CA3CA14ALDH1A1CA6IDUA
Glucuronate SCHEMBL6945670 0.86 IDUA (0.38) CA3CA14HIF1AALDH1A1CA6
Glucuronate SCHEMBL25253417 0.78 IDUA (0.50) HIF1AALDH1A1HSD17B10IDUACA12
Glucuronate SCHEMBL21792734 0.78 IDUA (0.50) HIF1AALDH1A1HSD17B10IDUACA12
Glucuronate SCHEMBL14406475 0.78 IDUA (0.50) HIF1AALDH1A1HSD17B10IDUACA12
Glucuronate SCHEMBL22749019 0.78 IDUA (0.50) HIF1AALDH1A1HSD17B10IDUACA12
Glucuronate SCHEMBL21312643 0.78 IDUA (0.50) HIF1AALDH1A1HSD17B10IDUACA12
Glucuronate SCHEMBL18163135 0.78 IDUA (0.50) HIF1AALDH1A1HSD17B10IDUACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8506947-B2 Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-08-13 US disclosed
EP-2325321-A1 A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-05-25 EP disclosed
US-20070154458-A1 Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector The Gov. of the USA as represented by the Sec. of the Dep. of Health & Human Services, 2007-07-05 US disclosed
US-7208313-B2 Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2007-04-24 US disclosed
US-20030031681-A1 Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT HEALTH AND HUMAN SERVICES, THE 2003-02-13 US disclosed